Bobby Reddy, Jr., PhD
Co-Founder / CEO / Board Member
Bobby has led the company from inception, driving company vision, building the team, securing clinical and strategic partnerships, and raising funds.
He has more than a decade of experience in the research and development of early screening technologies for debilitating diseases with a deep understanding of clinical issues. For several years, Bobby has worked intimately with a wide variety of clinical and administrative hospital personnel to comprehensively understand how technology can address the most critical issues they face. He received a PhD in electrical engineering from the University of Illinois at Urbana-Champaign, an M.S. in electrical engineering from the University of California, Irvine, and B.S. degrees in computer engineering and electrical engineering from the University of California, Irvine.
Follow on LinkedIn
Bobby Reddy, Jr. in the News
Check out the latest thought leadership contributions on AI innovation and acute care from our co-founder, CEO and board member.
Treating the Patient, Not the Disease
AI in Chicago: Breaking Through Healthcare’s Most Challenging Frontier
Transforming Sepsis Care with AI: Prenosis Delivers Innovation
Unite for Sepsis Symposium 2025: Highlights and Key Takeaways
The Virtual Shift: Sepsis Awareness Month with Bobby Reddy, Jr., PhD
Challenges Facing Developers of Diagnostic Tests for Sepsis: A Report From Sepsis Alliance and the Infection Management and Sepsis Collaborative Community
Multivariate protein landscape of host response in hospitalised patients with suspected infection in the emergency department
Bobby Reddy, Jr. Named to TIME’s 2025 TIME100 Health List
Biomarker-based Clustering to Identify Distinct Host Response Signatures in Hospitalized Patients With Suspected Infection
Prenosis CEO Bobby Reddy, Jr. Recognized Among Crain’s Chicago 40 Under 40
